Financials
- Market Capitalization 351.79 M
- Employee 533
- Founded 2002
- CEO N/A
- Website www.vandapharma.com
- Headquarter Delaware, United States
- FIGI BBG000HT5MG6
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.7
Rapporto prezzo/fatturato
1.88
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3148 | XFOR X4 Pharmaceuticals, Inc. - Common Stock | 3.84 USD | -4.48% | -1.79% | -6.34% | +29.29% | 362.19 M USD | ||
| 3179 | LXEO Lexeo Therapeutics, Inc. - Common Stock | 4.69 USD | +1.52% | -7.31% | -0.64% | +12.74% | 368.27 M USD | ||
| 3210 | PRLD Prelude Therapeutics Incorporated - Common Stock | 4.50 USD | +2.51% | -10.89% | +2.97% | +455.56% | 358.40 M USD | ||
| 3217 | FATE Fate Therapeutics, Inc. - Common Stock | 2.92 USD | -2.34% | +0.34% | +43.84% | +156.14% | 340.35 M USD |